
MTHFR Myths
Reality of MTHFR:
[1]Levin BL et al. (2016). “MTHFR: Addressing Genetic Counseling Dilemmas Using Evidence-Based Literature.” J Genet Couns. https://www.ncbi.nlm.nih.gov/pubmed/27130656
[2]Moll S et al. (2015). “Homocysteine and MTHFR Mutations.” Circulation. 132(1):e6-9. https://www.ncbi.nlm.nih.gov/pubmed/26149435
[3]Klerk M et al. (2002). “MTHFR 677C–>T polymorphism and risk of coronary heart disease: a meta-analysis.” JAMA. 288(16):2023-31. https://www.ncbi.nlm.nih.gov/pubmed/12387655
[4]Clarke R et al. (2012). “Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.” PLoS Med. 9(2):e1001177. https://www.ncbi.nlm.nih.gov/pubmed/22363213
[5]Kumar P et al. (2015). “Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibility.” Meta Gene. 6:72-84. https://www.ncbi.nlm.nih.gov/pubmed/26629412
[6]Teng Z et al. (2013). “The 677C>T () polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies.” PLoS One. 8(2):e55332. https://www.ncbi.nlm.nih.gov/pubmed/23437053
[7]Den Heijer M et al. (2005). “Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.” J Thromb Haemost. 3(2):292-9. https://www.ncbi.nlm.nih.gov/pubmed/15670035
[8]Gouveia LO et al. (2010). “MTHFR and the risk for cerebral venous thrombosis–a meta-analysis.” Thromb Res. 125(4):e153-8. https://www.ncbi.nlm.nih.gov/pubmed/19926119
[9]Pu D et al. (2013). “Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis.” Autism Res. 6(5):384-92. https://www.ncbi.nlm.nih.gov/pubmed/23653228
[10]Boccia S et al. (2008). “Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.” Am J Epidemiol. 167(5):505-16. https://www.ncbi.nlm.nih.gov/pubmed/18162478
[11]Yan L et al. (2012). “Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies.” PLoS One. 7(10):e41689. https://www.ncbi.nlm.nih.gov/pubmed/23056169
[12]Yang Y et al. (2015). “Association between MTHFR C677T polymorphism and neural tube defect risks: A comprehensive evaluation in three groups of NTD patients, mothers, and fathers.” Birth Defects Res A Clin Mol Teratol. 103(6):488-500. https://www.ncbi.nlm.nih.gov/pubmed/25808073
[13]Crider KS et al. (2011). “Folic acid food fortification-its history, effect, concerns, and future directions.” Nutrients. 3(3):370-84. https://www.ncbi.nlm.nih.gov/pubmed/22254102 [14]Hickey SE et al. (2013). “ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.” Genet Med. 15(2):153-6. https://www.ncbi.nlm.nih.gov/pubmed/23288205 [15]American College of Obstetricians and Gynecologists Women’s Health Care Physicians. (2013). “ACOG Practice Bulletin No. 138: Inherited thrombophilias in pregnancy.” Obstet Gynecol. 122(3):706-17. https://www.ncbi.nlm.nih.gov/pubmed/23963422 [16]Genetics Home Reference. “Homocystinuria.” https://ghr.nlm.nih.gov/condition/homocystinuria
Pingback: Quack Exposed: Spectrum Awakening - Fierce Autie
Pingback: Quack Exposed: Dr. Kendra Becker-Musante - Fierce Autie
Pingback: Quack Exposed: Dr. Richard Kunin → Fierce Autie